Celebrating 40+ Years!
Theradex Oncology is a full-service CRO, conducting early and late-phase oncology trials in the U.S, Europe and Asia. Theradex Oncology was founded in 1982, when we were awarded the Clinical Trials Monitoring Contract for the National Cancer Institute (NCI). Our ongoing association with NCI continues to be a strong basis for our operations. Our focus is cancer. We fully understand the science behind each potential cancer therapy and the challenges that come with moving therapies from mice to man. Theradex Oncology has designed and managed more than 250 early and late-phase oncology trials to date. Our mission is to assure that new discoveries in cancer drug development have the very best opportunity to be of benefit to mankind with a vision to improve treatment and make cancer a livable disease.
We are seeking a Study Start-Up Associate, level I or II dependent upon experience.
You will serve as the primary point of contact to study sites during start-up, work in a team setting managing multiple clinical study protocols and will be responsible for all regulatory tasks pertaining to assigned studies. This role will be involved in studies from start-up through maintenance and closeout.
The primary responsibilities of this position include, but are not limited to, the following:
Level of Education:
Prior Experience:
Additional Requirements:
Skills and Competencies needed:
What We Offer
We provide a supportive environment and through our expertise, innovative systems and processes and we give you the tools to be successful for ambitious and talented people that strive in a fast-paced entrepreneurial environment. We offer a competitive compensation and benefits package including medical, dental, vision, life insurance, short term/long term disability (STD/LTD), 401(k), tuition reimbursement, generous vacation/sick plans, flexible work schedules, employee discounts and much more.
This position does not offer company provided sponsorship or relocation assistance.
No agencies please.
Software Powered by iCIMS
www.icims.com